Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Moxidectin in Comparison to Ivermectin Against Strongyloides Stercoralis Infection in Adults: a Randomized Controlled Non-inferiority Trial

NCT04848688 is registered in ClinicalTrials.gov with Jennifer Keiser as lead sponsor.

NCT NCT04848688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04848688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Moxidectin in Comparison to Ivermectin Against Strongyloides Stercoralis Infection in Adults: a Randomized Controlled Non-inferiority Trial
Lead sponsor
Jennifer Keiser
Phase
Phase 3
Overall status
Completed
Start date
February 5, 2022
Completion date
July 17, 2022
Enrollment
332 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

strongyloides stercoralis infection